
1. Am J Trop Med Hyg. 2015 Oct;93(4):801-9. doi: 10.4269/ajtmh.15-0232. Epub 2015
Jul 6.

Genome-Scale Protein Microarray Comparison of Human Antibody Responses in
Plasmodium vivax Relapse and Reinfection.

Chuquiyauri R(1), Molina DM(1), Moss EL(1), Wang R(1), Gardner MJ(1), Brouwer
KC(1), Torres S(1), Gilman RH(1), Llanos-Cuentas A(1), Neafsey DE(1), Felgner
P(1), Liang X(1), Vinetz JM(2).

Author information: 
(1)Department of Medicine, Division of Infectious Diseases, University of
California San Diego, La Jolla, California; Laboratorio ICEMR-Amazonia,
Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía,
Universidad Peruana Cayetano Heredia, Lima, Perú; Instituto de Medicina Tropical 
Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú; Antigen
Discovery Inc., Irvine, California; Malaria Research Group, Broad Institute of
MIT and Harvard University, Cambridge, Massachusetts; Seattle Biomed, Seattle,
Washington; Department of Medicine, Division of Global Public Health, University 
of California San Diego, La Jolla, California; Department of International
Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
(2)Department of Medicine, Division of Infectious Diseases, University of
California San Diego, La Jolla, California; Laboratorio ICEMR-Amazonia,
Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía,
Universidad Peruana Cayetano Heredia, Lima, Perú; Instituto de Medicina Tropical 
Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú; Antigen
Discovery Inc., Irvine, California; Malaria Research Group, Broad Institute of
MIT and Harvard University, Cambridge, Massachusetts; Seattle Biomed, Seattle,
Washington; Department of Medicine, Division of Global Public Health, University 
of California San Diego, La Jolla, California; Department of International
Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
jvinetz@ucsd.edu.

Large scale antibody responses in Plasmodium vivax malaria remains unexplored in 
the endemic setting. Protein microarray analysis of asexual-stage P. vivax was
used to identify antigens recognized in sera from residents of hypoendemic
Peruvian Amazon. Over 24 months, of 106 participants, 91 had two symptomatic P.
vivax malaria episodes, 11 had three episodes, 3 had four episodes, and 1 had
five episodes. Plasmodium vivax relapse was distinguished from reinfection by a
merozoite surface protein-3α restriction fragment length polymorphism polymerase 
chain reaction (MSP3α PCR-RFLP) assay. Notably, P. vivax reinfection subjects did
not have higher reactivity to the entire set of recognized P. vivax blood-stage
antigens than relapse subjects, regardless of the number of malaria episodes. The
most highly recognized P. vivax proteins were MSP 4, 7, 8, and 10 (PVX_003775,
PVX_082650, PVX_097625, and PVX_114145); sexual-stage antigen s16 (PVX_000930);
early transcribed membrane protein (PVX_090230); tryptophan-rich antigen
(Pv-fam-a) (PVX_092995); apical merozoite antigen 1 (PVX_092275); and proteins of
unknown function (PVX_081830, PVX_117680, PVX_118705, PVX_121935, PVX_097730,
PVX_110935, PVX_115450, and PVX_082475). Genes encoding reactive proteins
exhibited a significant enrichment of non-synonymous nucleotide variation, an
observation suggesting immune selection. These data identify candidates for
seroepidemiological tools to support malaria elimination efforts in P.
vivax-endemic regions.

© The American Society of Tropical Medicine and Hygiene.

DOI: 10.4269/ajtmh.15-0232 
PMCID: PMC4596603
PMID: 26149860  [Indexed for MEDLINE]

